Title : Sorafenib in treatment of patients with advanced hepatocellular carcinoma: a systematic review.

Pub. Date : 2012 Oct

PMID : 23060390






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Subgroup analysis indicated that sorafenib was less effective in patients with extrahepatic spread (with: P=0.13 vs without: P<0.0001), with normal alpha-fetoprotein level (AFP) (P=0.15 vs elevated: P=0.0006), and with elevated level of serum bilirubin (P=0.06 vs normal: P=0.0009). Sorafenib alpha fetoprotein Homo sapiens
2 Subgroup analysis indicated that sorafenib was less effective in patients with extrahepatic spread (with: P=0.13 vs without: P<0.0001), with normal alpha-fetoprotein level (AFP) (P=0.15 vs elevated: P=0.0006), and with elevated level of serum bilirubin (P=0.06 vs normal: P=0.0009). Sorafenib alpha fetoprotein Homo sapiens
3 Meanwhile, sorafenib is less effective for patients with extrahepatic spread, with normal AFP level and with elevated level of bilirubin. Sorafenib alpha fetoprotein Homo sapiens